JPMorgan Chase & Co. Lowers Smith & Nephew (LON:SN) Price Target to GBX 1,243

Smith & Nephew (LON:SNGet Rating) had its price objective reduced by research analysts at JPMorgan Chase & Co. from GBX 1,442 ($17.67) to GBX 1,243 ($15.23) in a note issued to investors on Thursday, MarketBeat.com reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 16.11% from the stock’s current price.

Other equities analysts have also issued research reports about the stock. Barclays cut their price objective on shares of Smith & Nephew from GBX 1,630 ($19.97) to GBX 1,550 ($18.99) and set an “overweight” rating on the stock in a research report on Thursday. Royal Bank of Canada reissued an “outperform” rating and issued a GBX 1,700 ($20.83) price target on shares of Smith & Nephew in a research report on Thursday, July 21st. Credit Suisse Group dropped their price target on shares of Smith & Nephew from GBX 1,540 ($18.87) to GBX 1,400 ($17.15) and set an “outperform” rating on the stock in a research report on Thursday. Finally, Berenberg Bank dropped their price target on shares of Smith & Nephew from GBX 1,825 ($22.36) to GBX 1,490 ($18.26) and set a “buy” rating on the stock in a research report on Tuesday, July 26th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of GBX 1,476.60 ($18.09).

Smith & Nephew Price Performance

Shares of SN opened at GBX 1,070.50 ($13.12) on Thursday. The firm has a market cap of £9.34 billion and a PE ratio of 2,298.94. The firm’s 50 day moving average price is GBX 1,168.33 and its 200 day moving average price is GBX 1,221.05. The company has a debt-to-equity ratio of 53.62, a quick ratio of 0.84 and a current ratio of 1.78. Smith & Nephew has a twelve month low of GBX 1,002 ($12.28) and a twelve month high of GBX 1,440.89 ($17.66).

Insider Transactions at Smith & Nephew

In other news, insider Deepak Nath sold 26,529 shares of the firm’s stock in a transaction on Monday, May 16th. The shares were sold at an average price of GBX 1,278 ($15.66), for a total value of £339,040.62 ($415,440.04).

Smith & Nephew Company Profile

(Get Rating)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.

Read More

Analyst Recommendations for Smith & Nephew (LON:SN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.